The biosimilar supplement review system in the US will undergo a substantial expansion during the upcoming user fee cycle as part of an effort to streamline the process and create more certainty for sponsors.
BsUFA III Expands Biosimilar Supplement Review Goals To Speed Approvals
Six supplement categories based on submission content will be created with review goals between three and 10 months.
